Market Need Diabetic foot complications represent a large, preventable burden in chronic disease, signaling a clear demand for early risk screening and decision support that can reduce costs and amputations.

Product Fit Revealix offers a 3-minute workflow for screening, documenting, stratifying, and acting on risk, positioning it as a lightweight, high-velocity integration that can complement hospital workflows without heavy disruption.

Budget Signals With current revenue under one million and modest funding, there may be opportunities to pursue pilot programs or grant-enabled deployments in hospitals or health systems aiming to curb high-cost diabetic foot care.

Competitive Positioning Compared to larger incumbents, Revealix’s niche focus on prevention and early risk interception differentiates it in the hospital care continuum and can be pitched to facilities seeking value-based care outcomes.

Expansion Opportunities Potential sales plays include integrations with existing hospital IT stacks (AWS, Google Workspace) and simple commerce-enabled pilots, leveraging current tech stack to accelerate deployment and user adoption.